The Accretion Pharmaceuticals Limited IPO is opening for subscription on 14 May 2025 and will close on 16 May 2025. This SME IPO is raising ₹29.75 crore from a complete fresh issue of 29.46 lakh equity shares.
The Accretion Pharmaceuticals IPO allotment date will be decided on Monday, 19 May 2025. Accretion Pharmaceuticals shares will be listed on NSE SME on Wednesday, 21 May 2025, tentatively.
The Accretion Pharmaceuticals price band has been set between ₹96 and ₹101 per share. The lot size decided for the IPO is 1200 shares, which makes the minimum investment for the retail investors ₹115200. The HNIs need to subscribe to at least 2 lots, which makes the minimum investment ₹ 242400.
Here Are the Quick Steps to Apply for the Accretion Pharmaceuticals SME IPO with the Best IPO App!
Accretion Pharmaceuticals NSE SME IPO Details
| Detail | Information |
| IPO Opening Date | May 14, 2025 |
| IPO Closing Date | May 16, 2025 |
| Tentative IPO Listing Date | May 21, 2025 |
| Face Value | ₹10 per share |
| Price Range | ₹₹96 to ₹101 per share |
| Lot Size | 1200 shares |
| Total Issue Size | 2946000 Shares (₹29.75 Cr.) |
| Fresh Issue | 2946000 Shares (₹29.75 Cr.) |
| IPO Segment | Book Built Issue IPO |
| Listing At | NSE SME |
| Shareholding Pre-Issue | 8170000 shares |
| Shareholding post-issue | 11116000 shares |
Accretion Pharmaceuticals Limited | Company Overview
Accretion Pharmaceuticals Limited is engaged in producing different pharma and healthcare products. It was started back in 2012 and has ISO certifications such as ISO 9001:2015, ISO 14001:2015, and ISO 22000:2025, which dictate the quality of the products and other factors.
The products that the firm produces include –
- Tablets and capsules which include anti-inflammatory medicines, antibiotics, pain management, gastrointestinal medicines, cardiovascular medicines, etc.
- Oral liquids and syrups for digestive treatments, pediatric, and respiratory treatment.
- Ayurvedic and herbal products for natural wellness solutions for general health, digestion, immunity, etc.
- External medicines such as ointments, lotions, derma products, etc.
The manufacturing facility of the firm is located in the city of Ahmedabad, at Sanand in Gujarat.
Accretion Pharmaceuticals Limited IPO | Key Details
- Accretion Pharmaceuticals IPO Opening Date: May 14, 2025,
- Accretion Pharmaceuticals IPO Closing Date: May 16, 2025.
- Allotment Date: May 19, 2025
- Price Band: ₹96 to ₹101 per share
- Lot Size: 1200 shares
- Refunds Initiated: Mar 20, 2025
- Shares Credited to Demat: May 20, 2025
- Listing Date: May 21, 2025
Accretion Pharmaceuticals Ltd: Financial Overview
Accretion Pharmaceuticals Limited saw a breathtaking 3780% jump in its profit during FY24, that too when the revenue for the period grew by 14.93%.
Here are the details of the financials of firm –
Amounts in ₹ Crore
| Financial Information | 31-Mar-24 | 31-Mar-23 | Change | Change (%) |
| Assets | 27.05 | 20.58 | 6.47 | 31.4382896 |
| Revenue | 33.94 | 29.53 | 4.41 | 14.93396546 |
| Profit After Tax | 3.88 | 0.1 | 3.78 | 3780 |
| Net Worth | 5.35 | 3.84 | 1.51 | 39.32291667 |
| Reserve & Surplus | 1.35 | 0 | 1.35 | #DIV/0! |
| Total Borrowing | 13.48 | 8.47 | 5.01 | 59.14994097 |
Accretion Pharmaceuticals Ltd IPO | FAQs
Accretion Pharmaceuticals Ltd is engaged in the production of various types of medicines, pharma, and healthcare products.
The tentative IPO listing date of Accretion Pharmaceuticals has been fixed as Wednesday, May 21, 2025.
The bidding date for the Accretion Pharmaceuticals IPO is May 14, 2025, and it will continue until May 16, 2025.
The minimum IPO lot size for Accretion Pharmaceuticals is 1200 shares, and for HNIs, it is 2 lots.
The IPO allotment is expected to be finalized on Monday, May 19, 2025.
The IPO face value is set at ₹10 per share.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.